Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China · Delayed Price · Currency is CNY 56.96
-0.49 (-0.85%)
Apr 9, 2026, 3:00 PM CST
SHA:600276 Revenue
In the year 2025, Jiangsu Hengrui Pharmaceuticals Co.,Ltd had annual revenue of 31.63B CNY with 13.02% growth. Jiangsu Hengrui Pharmaceuticals Co.,Ltd had revenue of 8.44B in the quarter ending December 31, 2025, with 8.29% growth.
Revenue
31.63B
Revenue Growth
+13.02%
P/S Ratio
11.93
Revenue / Employee
1.54M
Employees
20,602
Market Cap
377.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 31.63B | 3.64B | 13.02% |
| Dec 31, 2024 | 27.98B | 5.16B | 22.63% |
| Dec 31, 2023 | 22.82B | 1.54B | 7.26% |
| Dec 31, 2022 | 21.28B | -4.63B | -17.87% |
| Dec 31, 2021 | 25.91B | -1.83B | -6.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| Shanghai Fosun Pharmaceutical (Group) | 41.66B |
| Yunnan Baiyao Group Co.,Ltd | 41.19B |
| China Resources Sanjiu Medical & Pharmaceutical | 31.60B |
| Humanwell Healthcare (Group) | 23.96B |
| Zhejiang NHU Company | 22.47B |
| Beijing Tongrentang | 17.26B |
| Changchun High-Tech Industry (Group) | 12.88B |